Olaparib D5

STABLE ISOTOPES


 
We Guarantee Best Price for this compound*
If you get a better price we will match the same.

 
This product has a 5% Discount Online | Login to view price instantly
Product Details

CAT No.# CS-Y-00072
Category Stable Isotopes
CAS 2143107-56-4
Molecular Weight 439.5
Molecular Formula C24H18D5FN4O3
Stock Status: In-Stock   View COA
Purity: >98%
Synonyms: 4-(3-(-d5)piperazinerobenzyl)phthalazin-1(2H)-one; 4-[[3-[[4-(Cyclopropylcarbonyl)-1-piperazinyl]carbonyl]-4-fluorophenyl]methyl]-1(2H)-phthalazinone D5; AZD 2281 D5; KU 0059436 D5; KU 59436 D5; 1-(Cyclopropylcarbonyl)-4-[5-[(3,4-dihydro-4-oxo-1-phthalazi
Application Notes: Labeled Olaparib, intended for use as an internal standard for the quantification of Olaparib by GC- or LC-mass spectrometry.
References: Weston, V.J. et al.: Blood, 116, 4578 (2010); Senra, J.M. et al.: Mol. Cancer Therap., 10, 1949 (2011); Schaefer, N.G. et al.: Nuc. Med. Comm., 32, 1046 (2011);
Shipping: Free Shipping for worldwide on order above 2000 USD
Olaparib D5 Worldwide Suppliers of Olaparib D5 Stable Isotopes Clearsynth CS-Y-00072

Product rating: 9 Olaparib D5 based on 20 ratings

  1. Stable Isotopes
  2. Olaparib D5

PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
6. BISPHENOL AF (RING-13C12)
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. Silodosin Metabolite
11. 2-Phenoxymethanesulfonanilide
12. Nimesulide EP Impurity A
13. Acetone HPLC
14. Ortho toluene sulfonic acid
15. Crisaborole m-Isomer
16. Riluzole (1604337)
17. Pheniramine impurity B
18. Palbociclib N-Glucuronide
19. Carpropamid
20. Olmesartan N1-Trityl Impurity




This page contains information about Olaparib D5 Cas 2143107-56-4 and its Stable Isotopes.

Olaparib D5 Olaparib D5 Worldwide Suppliers of Olaparib D5 Stable Isotopes Clearsynth 2143107-56-4

"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."